世界のIBS-C治療薬市場予測2023-2029：リナクロチド、ルビプロストン、浸透圧性下剤、刺激性下剤、その他

【英語タイトル】IBS-C Drugs Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8794
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：123
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のIBS-C治療薬市場規模と予測を収録しています。・世界のIBS-C治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のIBS-C治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のIBS-C治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リナクロチド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

IBS-C治療薬のグローバル主要企業は、Catalent Pharmaceuticals Solutions、 Nestle、 Abbott Laboratories、 Synergy Pharmaceuticals、 Sucampo Pharmaceuticals、 Novartis Pharma Ag、 Astellas Pharmaceuticals、 Ardelyx, Inc、 Synthetic Biologics, Inc、 Teva Pharmaceutical Industries、 Bama-Geve, SLU、 Ferring BV、 Ironwood Pharmaceuticals, Inc、 Salix Pharmaceuticals Ltd、 Norgine B.V、 Prometheus Laboratories Inc、 Actavis Nordic A/S、 Albireo Pharma Inc、 Yuhan Corp、 Astrazeneca Plc、 The Menarini Group、 Ono Pharmaceutical Co., Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、IBS-C治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のIBS-C治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のIBS-C治療薬市場：タイプ別市場シェア、2022年
・リナクロチド、ルビプロストン、浸透圧性下剤、刺激性下剤、その他

世界のIBS-C治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のIBS-C治療薬市場：用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界のIBS-C治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のIBS-C治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるIBS-C治療薬のグローバル売上、2018年-2023年
・主要企業におけるIBS-C治療薬のグローバル売上シェア、2022年
・主要企業におけるIBS-C治療薬のグローバル販売量、2018年-2023年
・主要企業におけるIBS-C治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Catalent Pharmaceuticals Solutions、 Nestle、 Abbott Laboratories、 Synergy Pharmaceuticals、 Sucampo Pharmaceuticals、 Novartis Pharma Ag、 Astellas Pharmaceuticals、 Ardelyx, Inc、 Synthetic Biologics, Inc、 Teva Pharmaceutical Industries、 Bama-Geve, SLU、 Ferring BV、 Ironwood Pharmaceuticals, Inc、 Salix Pharmaceuticals Ltd、 Norgine B.V、 Prometheus Laboratories Inc、 Actavis Nordic A/S、 Albireo Pharma Inc、 Yuhan Corp、 Astrazeneca Plc、 The Menarini Group、 Ono Pharmaceutical Co., Ltd

*************************************************************

・調査・分析レポートの概要
IBS-C治療薬市場の定義
市場セグメント
世界のIBS-C治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のIBS-C治療薬市場規模
世界のIBS-C治療薬市場規模：2022年 VS 2029年
世界のIBS-C治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのIBS-C治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のIBS-C治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リナクロチド、ルビプロストン、浸透圧性下剤、刺激性下剤、その他
IBS-C治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、オンライン薬局
IBS-C治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別IBS-C治療薬市場規模 2022年と2029年
地域別IBS-C治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Catalent Pharmaceuticals Solutions、 Nestle、 Abbott Laboratories、 Synergy Pharmaceuticals、 Sucampo Pharmaceuticals、 Novartis Pharma Ag、 Astellas Pharmaceuticals、 Ardelyx, Inc、 Synthetic Biologics, Inc、 Teva Pharmaceutical Industries、 Bama-Geve, SLU、 Ferring BV、 Ironwood Pharmaceuticals, Inc、 Salix Pharmaceuticals Ltd、 Norgine B.V、 Prometheus Laboratories Inc、 Actavis Nordic A/S、 Albireo Pharma Inc、 Yuhan Corp、 Astrazeneca Plc、 The Menarini Group、 Ono Pharmaceutical Co., Ltd
...

This report aims to provide a comprehensive presentation of the global market for IBS-C Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IBS-C Drugs. This report contains market size and forecasts of IBS-C Drugs in global, including the following market information:
Global IBS-C Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global IBS-C Drugs Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five IBS-C Drugs companies in 2022 (%)
The global IBS-C Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Linaclotide Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of IBS-C Drugs include Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc and Synthetic Biologics, Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS-C Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IBS-C Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, by Type, 2022 (%)
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
Global IBS-C Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global IBS-C Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IBS-C Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies IBS-C Drugs revenues share in global market, 2022 (%)
Key companies IBS-C Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies IBS-C Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of IBS-C Drugs, market overview.
Chapter 2: Global IBS-C Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of IBS-C Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IBS-C Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global IBS-C Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 IBS-C Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IBS-C Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IBS-C Drugs Overall Market Size
2.1 Global IBS-C Drugs Market Size: 2022 VS 2029
2.2 Global IBS-C Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global IBS-C Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top IBS-C Drugs Players in Global Market
3.2 Top Global IBS-C Drugs Companies Ranked by Revenue
3.3 Global IBS-C Drugs Revenue by Companies
3.4 Global IBS-C Drugs Sales by Companies
3.5 Global IBS-C Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 IBS-C Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers IBS-C Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 IBS-C Drugs Players in Global Market
3.8.1 List of Global Tier 1 IBS-C Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 IBS-C Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global IBS-C Drugs Market Size Markets, 2022 & 2029
4.1.2 Linaclotide
4.1.3 Lubiprostone
4.1.4 Osmotic Laxatives
4.1.5 Stimulant Laxatives
4.1.6 Others
4.2 By Type – Global IBS-C Drugs Revenue & Forecasts
4.2.1 By Type – Global IBS-C Drugs Revenue, 2018-2023
4.2.2 By Type – Global IBS-C Drugs Revenue, 2024-2029
4.2.3 By Type – Global IBS-C Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global IBS-C Drugs Sales & Forecasts
4.3.1 By Type – Global IBS-C Drugs Sales, 2018-2023
4.3.2 By Type – Global IBS-C Drugs Sales, 2024-2029
4.3.3 By Type – Global IBS-C Drugs Sales Market Share, 2018-2029
4.4 By Type – Global IBS-C Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IBS-C Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global IBS-C Drugs Revenue & Forecasts
5.2.1 By Application – Global IBS-C Drugs Revenue, 2018-2023
5.2.2 By Application – Global IBS-C Drugs Revenue, 2024-2029
5.2.3 By Application – Global IBS-C Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global IBS-C Drugs Sales & Forecasts
5.3.1 By Application – Global IBS-C Drugs Sales, 2018-2023
5.3.2 By Application – Global IBS-C Drugs Sales, 2024-2029
5.3.3 By Application – Global IBS-C Drugs Sales Market Share, 2018-2029
5.4 By Application – Global IBS-C Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global IBS-C Drugs Market Size, 2022 & 2029
6.2 By Region – Global IBS-C Drugs Revenue & Forecasts
6.2.1 By Region – Global IBS-C Drugs Revenue, 2018-2023
6.2.2 By Region – Global IBS-C Drugs Revenue, 2024-2029
6.2.3 By Region – Global IBS-C Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global IBS-C Drugs Sales & Forecasts
6.3.1 By Region – Global IBS-C Drugs Sales, 2018-2023
6.3.2 By Region – Global IBS-C Drugs Sales, 2024-2029
6.3.3 By Region – Global IBS-C Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America IBS-C Drugs Revenue, 2018-2029
6.4.2 By Country – North America IBS-C Drugs Sales, 2018-2029
6.4.3 US IBS-C Drugs Market Size, 2018-2029
6.4.4 Canada IBS-C Drugs Market Size, 2018-2029
6.4.5 Mexico IBS-C Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe IBS-C Drugs Revenue, 2018-2029
6.5.2 By Country – Europe IBS-C Drugs Sales, 2018-2029
6.5.3 Germany IBS-C Drugs Market Size, 2018-2029
6.5.4 France IBS-C Drugs Market Size, 2018-2029
6.5.5 U.K. IBS-C Drugs Market Size, 2018-2029
6.5.6 Italy IBS-C Drugs Market Size, 2018-2029
6.5.7 Russia IBS-C Drugs Market Size, 2018-2029
6.5.8 Nordic Countries IBS-C Drugs Market Size, 2018-2029
6.5.9 Benelux IBS-C Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia IBS-C Drugs Revenue, 2018-2029
6.6.2 By Region – Asia IBS-C Drugs Sales, 2018-2029
6.6.3 China IBS-C Drugs Market Size, 2018-2029
6.6.4 Japan IBS-C Drugs Market Size, 2018-2029
6.6.5 South Korea IBS-C Drugs Market Size, 2018-2029
6.6.6 Southeast Asia IBS-C Drugs Market Size, 2018-2029
6.6.7 India IBS-C Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America IBS-C Drugs Revenue, 2018-2029
6.7.2 By Country – South America IBS-C Drugs Sales, 2018-2029
6.7.3 Brazil IBS-C Drugs Market Size, 2018-2029
6.7.4 Argentina IBS-C Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa IBS-C Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa IBS-C Drugs Sales, 2018-2029
6.8.3 Turkey IBS-C Drugs Market Size, 2018-2029
6.8.4 Israel IBS-C Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia IBS-C Drugs Market Size, 2018-2029
6.8.6 UAE IBS-C Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Catalent Pharmaceuticals Solutions
7.1.1 Catalent Pharmaceuticals Solutions Company Summary
7.1.2 Catalent Pharmaceuticals Solutions Business Overview
7.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Major Product Offerings
7.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Catalent Pharmaceuticals Solutions Key News & Latest Developments
7.2 Nestle
7.2.1 Nestle Company Summary
7.2.2 Nestle Business Overview
7.2.3 Nestle IBS-C Drugs Major Product Offerings
7.2.4 Nestle IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Nestle Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories IBS-C Drugs Major Product Offerings
7.3.4 Abbott Laboratories IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 Synergy Pharmaceuticals
7.4.1 Synergy Pharmaceuticals Company Summary
7.4.2 Synergy Pharmaceuticals Business Overview
7.4.3 Synergy Pharmaceuticals IBS-C Drugs Major Product Offerings
7.4.4 Synergy Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Synergy Pharmaceuticals Key News & Latest Developments
7.5 Sucampo Pharmaceuticals
7.5.1 Sucampo Pharmaceuticals Company Summary
7.5.2 Sucampo Pharmaceuticals Business Overview
7.5.3 Sucampo Pharmaceuticals IBS-C Drugs Major Product Offerings
7.5.4 Sucampo Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sucampo Pharmaceuticals Key News & Latest Developments
7.6 Novartis Pharma Ag
7.6.1 Novartis Pharma Ag Company Summary
7.6.2 Novartis Pharma Ag Business Overview
7.6.3 Novartis Pharma Ag IBS-C Drugs Major Product Offerings
7.6.4 Novartis Pharma Ag IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Pharma Ag Key News & Latest Developments
7.7 Astellas Pharmaceuticals
7.7.1 Astellas Pharmaceuticals Company Summary
7.7.2 Astellas Pharmaceuticals Business Overview
7.7.3 Astellas Pharmaceuticals IBS-C Drugs Major Product Offerings
7.7.4 Astellas Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharmaceuticals Key News & Latest Developments
7.8 Ardelyx, Inc
7.8.1 Ardelyx, Inc Company Summary
7.8.2 Ardelyx, Inc Business Overview
7.8.3 Ardelyx, Inc IBS-C Drugs Major Product Offerings
7.8.4 Ardelyx, Inc IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Ardelyx, Inc Key News & Latest Developments
7.9 Synthetic Biologics, Inc
7.9.1 Synthetic Biologics, Inc Company Summary
7.9.2 Synthetic Biologics, Inc Business Overview
7.9.3 Synthetic Biologics, Inc IBS-C Drugs Major Product Offerings
7.9.4 Synthetic Biologics, Inc IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Synthetic Biologics, Inc Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries IBS-C Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.11 Bama-Geve, SLU
7.11.1 Bama-Geve, SLU Company Summary
7.11.2 Bama-Geve, SLU IBS-C Drugs Business Overview
7.11.3 Bama-Geve, SLU IBS-C Drugs Major Product Offerings
7.11.4 Bama-Geve, SLU IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Bama-Geve, SLU Key News & Latest Developments
7.12 Ferring BV
7.12.1 Ferring BV Company Summary
7.12.2 Ferring BV IBS-C Drugs Business Overview
7.12.3 Ferring BV IBS-C Drugs Major Product Offerings
7.12.4 Ferring BV IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Ferring BV Key News & Latest Developments
7.13 Ironwood Pharmaceuticals, Inc
7.13.1 Ironwood Pharmaceuticals, Inc Company Summary
7.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Business Overview
7.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Major Product Offerings
7.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Ironwood Pharmaceuticals, Inc Key News & Latest Developments
7.14 Salix Pharmaceuticals Ltd
7.14.1 Salix Pharmaceuticals Ltd Company Summary
7.14.2 Salix Pharmaceuticals Ltd Business Overview
7.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Major Product Offerings
7.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Salix Pharmaceuticals Ltd Key News & Latest Developments
7.15 Norgine B.V
7.15.1 Norgine B.V Company Summary
7.15.2 Norgine B.V Business Overview
7.15.3 Norgine B.V IBS-C Drugs Major Product Offerings
7.15.4 Norgine B.V IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Norgine B.V Key News & Latest Developments
7.16 Prometheus Laboratories Inc
7.16.1 Prometheus Laboratories Inc Company Summary
7.16.2 Prometheus Laboratories Inc Business Overview
7.16.3 Prometheus Laboratories Inc IBS-C Drugs Major Product Offerings
7.16.4 Prometheus Laboratories Inc IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Prometheus Laboratories Inc Key News & Latest Developments
7.17 Actavis Nordic A/S
7.17.1 Actavis Nordic A/S Company Summary
7.17.2 Actavis Nordic A/S Business Overview
7.17.3 Actavis Nordic A/S IBS-C Drugs Major Product Offerings
7.17.4 Actavis Nordic A/S IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Actavis Nordic A/S Key News & Latest Developments
7.18 Albireo Pharma Inc
7.18.1 Albireo Pharma Inc Company Summary
7.18.2 Albireo Pharma Inc Business Overview
7.18.3 Albireo Pharma Inc IBS-C Drugs Major Product Offerings
7.18.4 Albireo Pharma Inc IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Albireo Pharma Inc Key News & Latest Developments
7.19 Yuhan Corp
7.19.1 Yuhan Corp Company Summary
7.19.2 Yuhan Corp Business Overview
7.19.3 Yuhan Corp IBS-C Drugs Major Product Offerings
7.19.4 Yuhan Corp IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Yuhan Corp Key News & Latest Developments
7.20 Astrazeneca Plc
7.20.1 Astrazeneca Plc Company Summary
7.20.2 Astrazeneca Plc Business Overview
7.20.3 Astrazeneca Plc IBS-C Drugs Major Product Offerings
7.20.4 Astrazeneca Plc IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Astrazeneca Plc Key News & Latest Developments
7.21 The Menarini Group
7.21.1 The Menarini Group Company Summary
7.21.2 The Menarini Group Business Overview
7.21.3 The Menarini Group IBS-C Drugs Major Product Offerings
7.21.4 The Menarini Group IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.21.5 The Menarini Group Key News & Latest Developments
7.22 Ono Pharmaceutical Co., Ltd
7.22.1 Ono Pharmaceutical Co., Ltd Company Summary
7.22.2 Ono Pharmaceutical Co., Ltd Business Overview
7.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Major Product Offerings
7.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Ono Pharmaceutical Co., Ltd Key News & Latest Developments
8 Global IBS-C Drugs Production Capacity, Analysis
8.1 Global IBS-C Drugs Production Capacity, 2018-2029
8.2 IBS-C Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global IBS-C Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IBS-C Drugs Supply Chain Analysis
10.1 IBS-C Drugs Industry Value Chain
10.2 IBS-C Drugs Upstream Market
10.3 IBS-C Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IBS-C Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of IBS-C Drugs in Global Market
Table 2. Top IBS-C Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global IBS-C Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global IBS-C Drugs Revenue Share by Companies, 2018-2023
Table 5. Global IBS-C Drugs Sales by Companies, (K Pcs), 2018-2023
Table 6. Global IBS-C Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers IBS-C Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers IBS-C Drugs Product Type
Table 9. List of Global Tier 1 IBS-C Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IBS-C Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global IBS-C Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global IBS-C Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global IBS-C Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global IBS-C Drugs Sales (K Pcs), 2018-2023
Table 15. By Type - Global IBS-C Drugs Sales (K Pcs), 2024-2029
Table 16. By Application – Global IBS-C Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global IBS-C Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global IBS-C Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global IBS-C Drugs Sales (K Pcs), 2018-2023
Table 20. By Application - Global IBS-C Drugs Sales (K Pcs), 2024-2029
Table 21. By Region – Global IBS-C Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global IBS-C Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global IBS-C Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global IBS-C Drugs Sales (K Pcs), 2018-2023
Table 25. By Region - Global IBS-C Drugs Sales (K Pcs), 2024-2029
Table 26. By Country - North America IBS-C Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America IBS-C Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America IBS-C Drugs Sales, (K Pcs), 2018-2023
Table 29. By Country - North America IBS-C Drugs Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe IBS-C Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe IBS-C Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe IBS-C Drugs Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe IBS-C Drugs Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia IBS-C Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia IBS-C Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia IBS-C Drugs Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia IBS-C Drugs Sales, (K Pcs), 2024-2029
Table 38. By Country - South America IBS-C Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America IBS-C Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America IBS-C Drugs Sales, (K Pcs), 2018-2023
Table 41. By Country - South America IBS-C Drugs Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa IBS-C Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa IBS-C Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa IBS-C Drugs Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa IBS-C Drugs Sales, (K Pcs), 2024-2029
Table 46. Catalent Pharmaceuticals Solutions Company Summary
Table 47. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Offerings
Table 48. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Catalent Pharmaceuticals Solutions Key News & Latest Developments
Table 50. Nestle Company Summary
Table 51. Nestle IBS-C Drugs Product Offerings
Table 52. Nestle IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Nestle Key News & Latest Developments
Table 54. Abbott Laboratories Company Summary
Table 55. Abbott Laboratories IBS-C Drugs Product Offerings
Table 56. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Abbott Laboratories Key News & Latest Developments
Table 58. Synergy Pharmaceuticals Company Summary
Table 59. Synergy Pharmaceuticals IBS-C Drugs Product Offerings
Table 60. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Synergy Pharmaceuticals Key News & Latest Developments
Table 62. Sucampo Pharmaceuticals Company Summary
Table 63. Sucampo Pharmaceuticals IBS-C Drugs Product Offerings
Table 64. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Sucampo Pharmaceuticals Key News & Latest Developments
Table 66. Novartis Pharma Ag Company Summary
Table 67. Novartis Pharma Ag IBS-C Drugs Product Offerings
Table 68. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Novartis Pharma Ag Key News & Latest Developments
Table 70. Astellas Pharmaceuticals Company Summary
Table 71. Astellas Pharmaceuticals IBS-C Drugs Product Offerings
Table 72. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Astellas Pharmaceuticals Key News & Latest Developments
Table 74. Ardelyx, Inc Company Summary
Table 75. Ardelyx, Inc IBS-C Drugs Product Offerings
Table 76. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Ardelyx, Inc Key News & Latest Developments
Table 78. Synthetic Biologics, Inc Company Summary
Table 79. Synthetic Biologics, Inc IBS-C Drugs Product Offerings
Table 80. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Synthetic Biologics, Inc Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Company Summary
Table 83. Teva Pharmaceutical Industries IBS-C Drugs Product Offerings
Table 84. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Teva Pharmaceutical Industries Key News & Latest Developments
Table 86. Bama-Geve, SLU Company Summary
Table 87. Bama-Geve, SLU IBS-C Drugs Product Offerings
Table 88. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Bama-Geve, SLU Key News & Latest Developments
Table 90. Ferring BV Company Summary
Table 91. Ferring BV IBS-C Drugs Product Offerings
Table 92. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Ferring BV Key News & Latest Developments
Table 94. Ironwood Pharmaceuticals, Inc Company Summary
Table 95. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Offerings
Table 96. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Ironwood Pharmaceuticals, Inc Key News & Latest Developments
Table 98. Salix Pharmaceuticals Ltd Company Summary
Table 99. Salix Pharmaceuticals Ltd IBS-C Drugs Product Offerings
Table 100. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Salix Pharmaceuticals Ltd Key News & Latest Developments
Table 102. Norgine B.V Company Summary
Table 103. Norgine B.V IBS-C Drugs Product Offerings
Table 104. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Norgine B.V Key News & Latest Developments
Table 106. Prometheus Laboratories Inc Company Summary
Table 107. Prometheus Laboratories Inc IBS-C Drugs Product Offerings
Table 108. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Prometheus Laboratories Inc Key News & Latest Developments
Table 110. Actavis Nordic A/S Company Summary
Table 111. Actavis Nordic A/S IBS-C Drugs Product Offerings
Table 112. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. Actavis Nordic A/S Key News & Latest Developments
Table 114. Albireo Pharma Inc Company Summary
Table 115. Albireo Pharma Inc IBS-C Drugs Product Offerings
Table 116. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 117. Albireo Pharma Inc Key News & Latest Developments
Table 118. Yuhan Corp Company Summary
Table 119. Yuhan Corp IBS-C Drugs Product Offerings
Table 120. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 121. Yuhan Corp Key News & Latest Developments
Table 122. Astrazeneca Plc Company Summary
Table 123. Astrazeneca Plc IBS-C Drugs Product Offerings
Table 124. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 125. Astrazeneca Plc Key News & Latest Developments
Table 126. The Menarini Group Company Summary
Table 127. The Menarini Group IBS-C Drugs Product Offerings
Table 128. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 129. The Menarini Group Key News & Latest Developments
Table 130. Ono Pharmaceutical Co., Ltd Company Summary
Table 131. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Offerings
Table 132. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 133. Ono Pharmaceutical Co., Ltd Key News & Latest Developments
Table 134. IBS-C Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 135. Global IBS-C Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 136. Global IBS-C Drugs Production by Region, 2018-2023 (K Pcs)
Table 137. Global IBS-C Drugs Production by Region, 2024-2029 (K Pcs)
Table 138. IBS-C Drugs Market Opportunities & Trends in Global Market
Table 139. IBS-C Drugs Market Drivers in Global Market
Table 140. IBS-C Drugs Market Restraints in Global Market
Table 141. IBS-C Drugs Raw Materials
Table 142. IBS-C Drugs Raw Materials Suppliers in Global Market
Table 143. Typical IBS-C Drugs Downstream
Table 144. IBS-C Drugs Downstream Clients in Global Market
Table 145. IBS-C Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. IBS-C Drugs Segment by Type in 2022
Figure 2. IBS-C Drugs Segment by Application in 2022
Figure 3. Global IBS-C Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global IBS-C Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global IBS-C Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. IBS-C Drugs Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by IBS-C Drugs Revenue in 2022
Figure 9. By Type - Global IBS-C Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global IBS-C Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global IBS-C Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global IBS-C Drugs Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global IBS-C Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global IBS-C Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global IBS-C Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global IBS-C Drugs Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global IBS-C Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global IBS-C Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global IBS-C Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global IBS-C Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America IBS-C Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America IBS-C Drugs Sales Market Share, 2018-2029
Figure 23. US IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe IBS-C Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe IBS-C Drugs Sales Market Share, 2018-2029
Figure 28. Germany IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia IBS-C Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia IBS-C Drugs Sales Market Share, 2018-2029
Figure 37. China IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America IBS-C Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America IBS-C Drugs Sales Market Share, 2018-2029
Figure 44. Brazil IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa IBS-C Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa IBS-C Drugs Sales Market Share, 2018-2029
Figure 48. Turkey IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE IBS-C Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global IBS-C Drugs Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production IBS-C Drugs by Region, 2022 VS 2029
Figure 54. IBS-C Drugs Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界のIBS-C治療薬市場予測2023-2029：リナクロチド、ルビプロストン、浸透圧性下剤、刺激性下剤、その他] (コード：MMG23LY8794)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のIBS-C治療薬市場予測2023-2029：リナクロチド、ルビプロストン、浸透圧性下剤、刺激性下剤、その他]についてメールでお問い合わせ

MarketReport.jp

世界のIBS-C治療薬市場予測2023-2029：リナクロチド、ルビプロストン、浸透圧性下剤、刺激性下剤、その他

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp